# Dolby Laboratories, Inc.: Form SCHEDULE 13D/A, filed Feb 13, 2026

- Company: [Dolby Laboratories, Inc.](/companies/dlb.md) (CIK 1308547)
- Form: SCHEDULE 13D/A
- Filed: 2026-02-13
- Accepted by EDGAR: Feb 13, 2026, 17:33 ET
- Period: not reported
- Accession: 0001193125-26-051828
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1308547/000119312526051828/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1308547/000119312526051828/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1308547/000119312526051828/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Feb 13, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-051828. Last ingested by Listed: Nov 14, 2026, 23:59 ET. No prices; not investment advice.
